PMV Pharmaceuticals, Inc (PMVP) is a publicly traded Healthcare sector company. As of May 21, 2026, PMVP trades at $1.31 with a market cap of $66.66M and a P/E ratio of -0.88. PMVP moved +0.00% today. Year to date, PMVP is +7.38%; over the trailing twelve months it is +40.74%. Its 52-week range spans $0.81 to $1.88. Analyst consensus is strong buy with an average price target of $4.50. Rallies surfaces PMVP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PMV Pharmaceuticals, Inc (PMVP) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PMVP moved +0.00% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $1.31 |
| Market Cap | $66.66M |
| P/E Ratio | -0.88 |
| EPS | $-1.49 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.88 |
| 52-Week Low | $0.81 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $5.38M |
| Net Income | $-78.34M |
| Gross Margin | 0.00% |
3 analysts cover PMVP: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.50.